Abstracts tagged "arthritis management"

Abstract Number: 2015 • 2013 ACR/ARHP Annual Meeting
Sarcoid Arthritis In World Trade Center Exposed New York City Firefighters Presenting As a Unique Clinical Subset
Konstantinos Loupasakis¹, Jessica Berman², Michelle S Glaser^3,4, Nadia Jaber⁴, Rachel Zeig-Owens^3,4, Mayris P Webber^4,5, Michael D Weiden^4,6, Anna Nolan^4,7, Kerry J Kelly⁴ and David J Prezant^4,8, ¹Rheumatology, Hospital for Special Surgery Weill Cornell Medical College, New York, NY, ²Rheumatology, Hospital for Special Surgery, Weill Cornell Medical College, New York, NY, ³Medicine, Montefiore Medical Center, Bronx, NY, ⁴Bureau of Health Services Fire Department of New York, Brooklyn, NY, ⁵Medicine and Epideiology and Population Health, Montefiore Medical Center Albert Einstein College of Medicine, Bronx, NY, ⁶Pulmonary, Critical Care and Sleep Medicine, New York University School of Medicine, New York, NY, ⁷Medicine, New York University School of Medicine, New York, NY, ⁸Montefiore Medical Center Albert Einstein College of Medicine, Bronx, NY
Background/Purpose: Sarcoidosis is a multisystem disease characterized by the formation of non-caseating granulomas with lungs being predominantly affected and the joints in up to 40%.…
Abstract Number: 1931 • 2013 ACR/ARHP Annual Meeting
Models Of Care For Arthritis: Drivers, Facilitators and Barriers To Their Development and Implementation
Aileen M. Davis¹, Cheryl Cott², Rose Wong³, Michel Landry⁴, Linda Li⁵, Allyson Jones⁶, Cy Frank⁷, Sydney C. Lineker⁸, Louise Bergeron⁹, Gillian A. Hawker¹⁰, Dianne P. Mosher¹¹, Vandana Ahluwalia¹², Michel Zummer¹³, Susan B. Jaglal¹⁴, Rhona McGlasson¹⁵, Richard Birtwhistle¹⁶, Sherry Bar¹⁷ and Elizabeth M. Badley¹⁸, ¹Division of Health Care and Outcomes Research, Toronto Western Research Institute, University Health Network, Ontario, ON, Canada, ²Divison of Health Care and Outcomes Research, Toronto Western Research Institute, University Health Network, Toronto, ON, Canada, ³Division of Health Care & Outcomes Research, Toronto Western Research Institute, University Health Network, Toronto, ON, Canada, ⁴Department of Community and Family Medicine, Physical Therapy Division, Duke University Medical Center, Durham, NC, ⁵Arthritis Centre of Canada and Department of Physical Therapy, University of British Columbia, Vancouver, BC, Canada, ⁶Department of Physical Therapy, University of Alberta, Edmonton, AB, Canada, ⁷Alberta Bone and Joint Institute and Department of Surgery, University of Calgary, Calgary, AB, Canada, ⁸The Arthritis Society, Toronto, ON, Canada, ⁹Canadian Arthritis Patient Alliance, Ottawa, ON, Canada, ¹⁰Women's College Research Institute, University of Toronto, Toronto, ON, Canada, ¹¹Med, University of Calgary, Calgary, AB, Canada, ¹²Past President, Ontario Rheumatology Association, Brampton, ON, Canada, ¹³Rheumatology, Ch Maisonneuve-Rosemont, Montreal, QC, Canada, ¹⁴Department of Physical Therapy, Department of Physical Therapy, University of Toronto, Toronto, ON, Canada, ¹⁵Bone and Joint Canada, Toronto, ON, Canada, ¹⁶Centre for Studies in Primary Care and Family Medicine and Community Health and Epidemiology, Queen's University, Kingston, ON, Canada, ¹⁷British Columbia Ministry of Health Services, Victoria, BC, Canada, ¹⁸Division of Health Care and Outcomes Research, Toronto Western Research Institute, University Health Network, Toronto, ON, Canada
Background/Purpose: Management of arthritis is a growing concern given disease prevalence and limited health care resources. In the context of a larger project investigating innovative…
Abstract Number: 1586 • 2013 ACR/ARHP Annual Meeting
Defining Hand Arthritis In Systemic Lupus Erythematosus, From An Ultrasound, Magnetic Resonance Imaging and Antibody Status Perspective
Elisabeth M.A Ball¹, Arthur Grey², Ai Lyn Tan³, Eiji Fukuba⁴, Gunter Steiner⁵, Dennis McGonagle⁶, Aubrey Bell⁷ and Madeleine Rooney⁸, ¹Rheumatology, Queens' University/Musgrave Park Hospital, Belfast, United Kingdom, ²Rheumatology, Musgrave Park Hospital, Belfast, United Kingdom, ³Leeds Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds, Leeds, United Kingdom, ⁴Department of Radiology, Shimane University, Izuma, Japan, ⁵Internal Medicine III, Division of Rheumatology, Medical University of Vienna, Vienna, Austria, ⁶NIHR Leeds Musculoskeletal Biomedical Research Unit, University of Leeds, Leeds, United Kingdom, ⁷Rheumatology Unit, Musgrave Park Hospital, Belfast, United Kingdom, ⁸Medicine, Queens University Belfast, Belfast, United Kingdom
Background/Purpose: Musculoskeletal involvement in systemic lupus erythematosus (SLE) is common but poorly characterised with only a few Magnetic Resonance Imaging (MRI) or ultrasound (US) studies…

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].